Matches in SemOpenAlex for { <https://semopenalex.org/work/W2383238287> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2383238287 endingPage "8" @default.
- W2383238287 startingPage "354" @default.
- W2383238287 abstract "To study the biological characters of tumor cell vaccines modified by interleukin 12 (IL-12) and co-stimulatory molecule B(7 - 1) and their combination therapeutic effect on rat ovarian cancer animal model.Retroviral vector pLmB(7 - 1)SN, which expressed murine B(7 - 1) was constructed. An epithelial ovarian cancer cell line NuTu-19 was infected with pLmIL-12SN and/or pLmB(7 - 1)SN by lipofectin-mediated gene transfer system. Cell lines that could highly express either or both of these cytokines were named NuTu-19/IL-12, NuTu-19/B(7 - 1) or NuTu-19/IL-12-B(7 - 1), according to the results of enzyme-linked immunosorbent assay (ELISA) and flow cytometry (FCM). NuTu-19/Neo, the cell line that was transfected by vector pLXSN was used as a control. Various types of cytokine-modified tumor cells were injected subcutaneously into syngeneic rats Fischer 344 and their tumorigenecities were recorded. After being immunized twice by various types of mitomycin C treated gene modified tumor cells, the survival time of the intraperitoneal disseminating ovarian cancer animal model was observed, and the anti-tumor mechanisms of different gene modified tumor cell lines were discussed.The reconstruction of pLmB(7 - 1)SN was successful. Stable IL-12 and B(7 - 1) expression in cell lines NuTu-19/B(7 - 1), NuTu-19/IL-12 and NuTu-19/IL-12-B(7 - 1) were confirmed by ELISA and FCM. Tumorigenecities of various gene modified tumor cells decreased in syngeneic rats. The splenic lymphocytes proliferation indices (PI) in B(7 - 1) group (NuTu-19/B(7 - 1) immunized group) and IL-12 group (NuTu-19/IL-12 immunized group) were 2.4 and 4.6 (the letter P < 0.05 compared with that in control group), while PI in B(7 - 1) and IL-12 combination group (NuTu-19/IL-12-B(7 - 1) immunized group) increase to 10.2, being of significantly difference compared with those in control or B(7 - 1) or IL - 12 group (P < 0.01). More significant cytotoxic effects of cytotoxic lymphocytes (CTLs) on syngeneic tumor cells could be observed in B(7 - 1) group (15.0%) or IL-12 group (31.5%) (P < 0.05 or P < 0.01, compared with 2.6% in control group), while coexpression of IL-12 and B(7 - 1) was of great importance in enhancing CTL activity (52.4%), compared with that in control or B(7 - 1) or IL-12 group (P < 0.05, respectively). The life spans of ovarian cancer-bearing rats immunized by IL-12 (59.8 d) or B(7 - 1) (56.2 d) tumor cell vaccines were a little longer than that in control group (53.4 d), but no significant differences existed (P > 0.05), whereas in the animal models who had received IL-12 and B(7 - 1) co-immunization, prolonged survival time was showed which had statistical significance compared with that in control group (66.0 d, P < 0.05).B(7 - 1) and IL-12 modified tumor cell vaccines can induce anti-tumor immunity through stimulating lymphocytes proliferation and inducing recognition and cytotoxic effects of CTLs on tumor cells. An obvious synergistic effect exists when the two cytokines are combined. Combined immunogenic therapy with IL-12 and B(7 - 1) should prove to be a promising therapeutic strategy in ovarian cancer." @default.
- W2383238287 created "2016-06-24" @default.
- W2383238287 creator A5030050478 @default.
- W2383238287 creator A5047741217 @default.
- W2383238287 creator A5052226334 @default.
- W2383238287 creator A5055832811 @default.
- W2383238287 creator A5074856125 @default.
- W2383238287 date "2003-06-01" @default.
- W2383238287 modified "2023-10-14" @default.
- W2383238287 title "[Study of the therapeutic effects of costimulatory molecules B7-1 and interleukin 12 modified tumor cells vaccines on ovarian epithelial carcinoma through induction of anti-cancer immunity of the body]." @default.
- W2383238287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12895379" @default.
- W2383238287 hasPublicationYear "2003" @default.
- W2383238287 type Work @default.
- W2383238287 sameAs 2383238287 @default.
- W2383238287 citedByCount "0" @default.
- W2383238287 crossrefType "journal-article" @default.
- W2383238287 hasAuthorship W2383238287A5030050478 @default.
- W2383238287 hasAuthorship W2383238287A5047741217 @default.
- W2383238287 hasAuthorship W2383238287A5052226334 @default.
- W2383238287 hasAuthorship W2383238287A5055832811 @default.
- W2383238287 hasAuthorship W2383238287A5074856125 @default.
- W2383238287 hasConcept C121608353 @default.
- W2383238287 hasConcept C153911025 @default.
- W2383238287 hasConcept C203014093 @default.
- W2383238287 hasConcept C2777371288 @default.
- W2383238287 hasConcept C2778690821 @default.
- W2383238287 hasConcept C2780427987 @default.
- W2383238287 hasConcept C502942594 @default.
- W2383238287 hasConcept C54009773 @default.
- W2383238287 hasConcept C54355233 @default.
- W2383238287 hasConcept C553184892 @default.
- W2383238287 hasConcept C81885089 @default.
- W2383238287 hasConcept C86803240 @default.
- W2383238287 hasConceptScore W2383238287C121608353 @default.
- W2383238287 hasConceptScore W2383238287C153911025 @default.
- W2383238287 hasConceptScore W2383238287C203014093 @default.
- W2383238287 hasConceptScore W2383238287C2777371288 @default.
- W2383238287 hasConceptScore W2383238287C2778690821 @default.
- W2383238287 hasConceptScore W2383238287C2780427987 @default.
- W2383238287 hasConceptScore W2383238287C502942594 @default.
- W2383238287 hasConceptScore W2383238287C54009773 @default.
- W2383238287 hasConceptScore W2383238287C54355233 @default.
- W2383238287 hasConceptScore W2383238287C553184892 @default.
- W2383238287 hasConceptScore W2383238287C81885089 @default.
- W2383238287 hasConceptScore W2383238287C86803240 @default.
- W2383238287 hasIssue "6" @default.
- W2383238287 hasLocation W23832382871 @default.
- W2383238287 hasOpenAccess W2383238287 @default.
- W2383238287 hasPrimaryLocation W23832382871 @default.
- W2383238287 hasRelatedWork W2013633321 @default.
- W2383238287 hasRelatedWork W2032360738 @default.
- W2383238287 hasRelatedWork W2350572624 @default.
- W2383238287 hasRelatedWork W2372052810 @default.
- W2383238287 hasRelatedWork W2376061827 @default.
- W2383238287 hasRelatedWork W2385428641 @default.
- W2383238287 hasRelatedWork W2386668924 @default.
- W2383238287 hasRelatedWork W2391530185 @default.
- W2383238287 hasRelatedWork W2409479742 @default.
- W2383238287 hasRelatedWork W3029927029 @default.
- W2383238287 hasVolume "38" @default.
- W2383238287 isParatext "false" @default.
- W2383238287 isRetracted "false" @default.
- W2383238287 magId "2383238287" @default.
- W2383238287 workType "article" @default.